EFFECTIVENESS OF JOSAMYCIN IN SARS IN NEWBORN AND INFANT CHILDREN

FULL TEXT:

Abstract

Annotation. Pneumonia is one of the most common diseases that occupies a leading place in the structure of morbidity and mortality from infectious diseases in children, manifested by symptoms of respiratory failure. We treated him with an antibacterial drug - josamycin. The aim of the work is to study the effectiveness of the use of the drug Josamycin in atypical pneumonia in children. Materials and methods of research: depending on the prescribed therapy, we treated 60 patients aged 3 to 10 years, who were divided into 2 groups. The patients were hospitalized in the Samarkand Branch of the Republican Scientific Center for Emergency Medical Care, in the departments of pediatrics. 30 patients were prescribed Josamycin at the age dosage for 10 days. Clinical manifestations of group I, who received the drug Josamycin stopped almost 2 times faster, compared with patients from group II. The use of Josamycin in SARS has shown that it is an effective drug that prevents and reduces the severity of pneumonia.

About the Authors

List of references

Demko I.V., Chubarova S.V., Gordeeva N.V., Zeleny S.V., etc.; Diagnostic algorithms and protocols for providing medical care for pneumonia : guidelines for doctors. Ministry of Health of the Krasnoyarsk Territory, GBOU VPO KrasSMU named after Prof VF Voino-Yasenetsky of the Ministry of Health of the Russian Federation M 2015:75.

Fedorovna IM. THE INFLUENCE OF RISK FACTORS ON THE DEVELOPMENT OF ATYPICAL PNEUMONIA IN YOUNG CHILDREN. Asian Journal of Pharmaceutical and Biological Research 2022;11.

Shavazi N., Ibragimova M. The use of polyoxidonium in the treatment of obstructive bronchitis in children. International Journal of Scientific Pediatrics 2023;1:26–8.

Gorbich ОА. Atypical pneumonia is a significant problem of childhood 2016.

Ochilova S., Aliev SHAR, Edgorova N. Etiological role and analysis of mycoplasmas in children with acute and chronic pneumonia. Biology and integrative medicine 2016:74–84.

Ibragimova M. F. Diagnostic criteria for pneumonia of atypical etiology in children. British Medical Journal 2022;2.

Platnikov A.L., Girina A.A., Maikova I.D., Koroed N.V., Lepiseva I.V., Sventsitskaya V.I., Logacheva T.S. CLINIC, DIAGNOSIS AND TREATMENT OF RESPIRATORY MYCOPLASMA PNEUMONIAE INFECTION IN CHILDREN. Medical advice 2019:86–93.

Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev 2017;30:747–809. https://doi.org/10.1128/CMR.00114-16.

How to Cite

Shavazi Н. ., & Ibragimova М. . (2023). EFFECTIVENESS OF JOSAMYCIN IN SARS IN NEWBORN AND INFANT CHILDREN. International Journal of Scientific Pediatrics, 2(2), 44–46. https://doi.org/10.56121/2181-2926-2023-2-2-44-46
Views: 131

Most read articles by the same author(s)